NCT03834363 - Morphine or Fentanyl for Refractory Dyspnea in COPD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

May 24, 2024

Study Completion Date

August 24, 2024

Conditions

COPD

Interventions

DRUG

Fentanyl

Fentanylpatch 12 mcg/hr, change patch every three days.

DRUG

Morphine Retard

Morphine retard capsules 10 mg bid.

DRUG

Placebo patch

Placebo patch, change patch every three days.

DRUG

Placebo oral capsule

Placebo oral capsule bid

Trial Locations (10)

9401 RK

Wilhelmina Ziekenhuis Assen, Assen

5707 HA

Elkerliek Ziekenhuis, Helmond

1815 JD

Noordwest Ziekenhuisgroep Alkmaar, Alkmaar

1942 LE

Rode Kruis Ziekenhuis, Beverwijk

2035 RC

Spaarne Gasthuis, Haarlem

7512 KZ

Medisch Spectrum Twente, Enschede

8025 AB

Isala Klinieken, Zwolle

9676 BJ

Ommelander Ziekenhuis Groningen, Scheemda

3083 AN

Ikazia Ziekenhuis, Rotterdam

9713GZ

University Medical Center Groningen, Groningen

All Listed Sponsors

collaborator

Dutch Foundation for Asthma Prevention

UNKNOWN

collaborator

Innovatiefonds Zorgverzekeraars

OTHER

lead

Huib A.M. Kerstjens

OTHER